aamc.org does not support this web browser. Learn more about the browsers we support.

New section

Content Background

New section

AAMC Statement on Approval of COVID-19 Vaccines

October 6, 2020

New section

New section

MEDIA CONTACTS
Stuart Heiser, Sr. Media Relations Specialist

 AAMC (Association of American Medical Colleges) Chief Scientific Officer Ross McKinney, Jr., MD and AAMC President and CEO David J. Skorton, MD, issued the following statement on the approval of COVID-19 vaccines:

“To maintain public faith in a COVID-19 vaccine, as well as to optimally assure the safety and effectiveness of new products for widespread public distribution, the AAMC recommends that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) evaluate any candidate vaccines prior to the FDA issuing an emergency use authorization.
 
Full approval of a new vaccine or biologic requires demonstration of safety and effectiveness through a process that includes evaluation by the VRBPAC. Their recommendations are considered by FDA staff who ultimately have the authority to approve the new product.

Stopping the COVID-19 pandemic demands our best science and our best approval processes. The health of our nation depends on it.”

New section

New section


The AAMC (Association of American Medical Colleges) is a not-for-profit association dedicated to transforming health through medical education, health care, medical research, and community collaborations. Its members are all 155 accredited U.S. and 17 accredited Canadian medical schools; more than 400 teaching hospitals and health systems, including Department of Veterans Affairs medical centers; and more than 70 academic societies. Through these institutions and organizations, the AAMC leads and serves America’s medical schools and teaching hospitals and their more than 179,000 full-time faculty members, 92,000 medical students, 140,000 resident physicians, and 60,000 graduate students and postdoctoral researchers in the biomedical sciences.